Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma

被引:67
|
作者
Berchtold, Sonja [1 ]
Gruenwald, Barbara [2 ]
Krueger, Achim [2 ]
Reithmeier, Anja [1 ]
Haehl, Teresa [1 ]
Cheng, Tao [3 ]
Feuchtinger, Annette [4 ]
Born, Diana [5 ]
Erkan, Mert [3 ,6 ]
Kleeff, Joerg [3 ]
Esposito, Irene [1 ]
机构
[1] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany
[2] Tech Univ Munich, Inst Expt Oncol & Therapy Res, D-80290 Munich, Germany
[3] Tech Univ Munich, Dept Surg, D-80290 Munich, Germany
[4] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt Pathol, Neuherberg, Germany
[5] Kantonspital Munsterlingen, Munsterlingen, Germany
[6] Koc Univ, Sch Med, Dept Surg, Istanbul, Turkey
基金
欧盟第七框架计划;
关键词
Collagen type V; beta; 1-integrin; Pancreatic ductal adenocarcinoma; Pancreatic stellate cells; Epithelial-stromal interaction; EHLERS-DANLOS-SYNDROME; STELLATE CELLS; EXTRACELLULAR-MATRIX; CANCER; EXPRESSION; STROMA; ADHESION; COL5A1; FIBRIL; IDENTIFICATION;
D O I
10.1016/j.canlet.2014.10.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Excessive matrix production by pancreatic stellate cells promotes local growth and metastasis of pancreatic ductal adenocarcinoma and provides a barrier for drug delivery. Collagen type V is a fibrillar, regulatory collagen up-regulated in the stroma of different malignant tumors. Here we show that collagen type V is expressed by pancreatic stellate cells in the stroma of pancreatic ductal adenocarcinoma and affects the malignant phenotype of various pancreatic cancer cell lines by promoting adhesion, migration and viability, also after treatment with chemotherapeutic drugs. Pharmacological and antibody-mediated inhibition of beta 1-integrin signaling abolishes collagen type V-induced effects on pancreatic cancer cells. Ablation of collagen type V secretion of pancreatic stellate cells by siRNA reduces invasion and proliferation of pancreatic cancer cells and tube formation of endothelial cells. Moreover, stable knockdown of collagen type V in pancreatic stellate cells reduces metastasis formation and angiogenesis in an orthotopic mouse model of ductal adenocarcinoma. In conclusion, paracrine loops involving cancer and stromal elements and mediated by collagen type V promote the malignant phenotype of pancreatic ductal adenocarcinoma and underline the relevance of epithelial-stromal interactions in the progression of this aggressive neoplasm. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 50 条
  • [1] Galectin-1 Secreted by Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma Stroma Promotes Proliferation and Invasion of Pancreatic Cancer Cells An In Vitro Study on the Microenvironment of Pancreatic Ductal Adenocarcinoma
    Xue, Xiaofeng
    Lu, Zipeng
    Tang, Dong
    Yao, Jie
    An, Yong
    Wu, Junli
    Li, Qiang
    Gao, Wentao
    Xu, Zekuan
    Qian, Zhuyin
    Dai, Cuncai
    Wei, Jishu
    Miao, Yi
    Jiang, Kuirong
    PANCREAS, 2011, 40 (06) : 832 - 839
  • [2] High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
    Li, He
    Li, Xiaocheng
    Lin, Huapeng
    Gong, Jianping
    MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 822 - 832
  • [3] Adrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells
    Xu, Min
    Qi, Feifei
    Zhang, Shaosen
    Ma, Xuhui
    Wang, Shan
    Wang, Chunying
    Fu, Yan
    Luo, Yongzhang
    ONCOTARGET, 2016, 7 (34) : 55043 - 55056
  • [4] Genomics of pancreatic ductal adenocarcinoma
    Pilarsky, Christian
    Gruetzmann, Robert
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2014, 13 (04) : 381 - 385
  • [5] Aquaporins in pancreatic ductal adenocarcinoma
    Bruun-Sorensen, Anne Sofie
    Edamana, Sarannya
    Login, Frederic H.
    Borgquist, Signe
    Nejsum, Lene N.
    APMIS, 2021, 129 (12) : 700 - 705
  • [6] Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
    Bermejo-Rodriguez, Camino
    Araos Henriquez, Joaquin
    Caligiuri, Giuseppina
    Pinto Teles, Sara
    Park, Youngkyu
    Evans, Anthony
    Barrera, Lawrence N.
    Neesse, Albrecht
    Gruetzmann, Robert
    Aust, Daniela
    Ruemmele, Petra
    Knoesel, Thomas
    Narita, Masako
    Narita, Masashi
    Campbell, Fiona
    Oehlund, Daniel
    Pilarsky, Christian
    Dow, Lukas E.
    Humbert, Patrick O.
    Biffi, Giulia
    Tuveson, David A.
    Perez-Mancera, Pedro A.
    CANCER RESEARCH, 2024, 84 (18) : 2968 - 2984
  • [7] Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma
    Penchev, Vesselin R.
    Chang, Yu-Tai
    Begum, Asma
    Ewachiw, Theodore
    Gocke, Christian
    Li, Joey
    McMillan, Ross H.
    Wang, Qiuju
    Anders, Robert
    Marchionni, Luigi
    Maitra, Anirban
    Uren, Aykut
    Rasheed, Zeshaan
    Matsui, William
    MOLECULAR CANCER RESEARCH, 2019, 17 (04) : 929 - 936
  • [8] PSC-induced Galectin-1 Promotes the Malignant Behavior of Pancreatic Ductal Adenocarcinoma
    Dong Tang
    Qi Wu
    Hong Peng Zhang
    Zhong Xu Yuan
    Jia Ming Xu
    Han Jian Zhu
    Jin Gao
    Zhuang Zhuang Liu
    Zhu Jiang Dai
    Xiao Ming Sun
    Meng Yue Xu
    Hui Wen Fang
    Zhen Li
    Chao Biao Lin
    Chun Feng Shi
    Dao Rong Wang
    Journal of Nutritional Oncology, 2019, 4 (03) : 121 - 131
  • [9] Proteomic Analysis of Malignant Ascites From Patients With Pancreatic Ductal Adenocarcinoma
    Kitamura, Fumimasa
    Miyata, Tatsunori
    Uemura, Norio
    Uchihara, Tomoyuki
    Imai, Katsunori
    Hayashi, Hiromitsu
    Yamashita, Yo-Ichi
    Matsusaki, Keisuke
    Ishimoto, Takatsugu
    Baba, Hideo
    ANTICANCER RESEARCH, 2021, 41 (06) : 2895 - 2900
  • [10] ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth
    Rath, Nicola
    Morton, Jennifer P.
    Julian, Linda
    Helbig, Lena
    Kadir, Shereen
    McGhee, Ewan J.
    Anderson, Kurt I.
    Kalna, Gabriela
    Mullin, Margaret
    Pinho, Andreia V.
    Rooman, Ilse
    Samuel, Michael S.
    Olson, Michael F.
    EMBO MOLECULAR MEDICINE, 2017, 9 (02) : 198 - 218